Tali Feferman

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Endothelial Cells

Immune Response

Candida Albicans

Top Venues

Science immunology

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Yoav Manaster, Zohar Shipony, Anat Hutzler, Masha Kolesnikov, Camila Avivi, Bruria Shalmon, Iris Barshack, Michal J Besser, Tali Feferman, Guy Shakhar
Reduced CTL motility and activity in avascular tumor areas. Cancer immunology, immunotherapy : CII 68 (8) (2019)